ALGN - Align Technology, Inc.
NEXT EARNINGS:
Apr 29, 2026
EPS Est: $2.33
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$194.30
DETAILS
HIGH:
$220.00
LOW:
$140.00
MEDIAN:
$200.00
CONSENSUS:
$194.30
UPSIDE:
4.73%
Market Cap:
13.31B
Volume:
1,235,846
Avg Volume:
1,306,261
52 Week Range:
122-208.31
Sector:
Healthcare
Industry:
Medical - Devices
Beta:
1.83
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
21,200
IPO Date:
2001-01-30
EPS (TTM):
5.66
P/E Ratio:
27.60
Revenue (TTM):
4.03B
Total Assets:
6.23B
Total Debt:
82.51M
Cash & Equiv:
1.09B
Rev Growth (5Y):
10.3%
EPS Growth (5Y):
-24.2%
FCF Growth (5Y):
3.2%
ROCE:
14.3%
Debt/Equity:
0.02
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-02-04 | $3.29 | $2.99 | +10.0% | $1.0B | $1.0B | +3.3% |
| 2025-10-29 | $2.61 | $2.40 | +8.8% | $995.7M | $976.4M | +2.0% |
| 2025-07-30 | $2.49 | $2.57 | -3.1% | $1.0B | $1.0B | -0.9% |
| 2025-04-30 | $2.13 | $1.99 | +7.0% | $979.3M | $975.2M | +0.4% |
| 2025-02-05 | $2.44 | $2.43 | +0.4% | $995.2M | $999.2M | -0.4% |
| 2024-10-23 | $2.35 | $2.31 | +1.7% | $977.9M | $990.0M | -1.2% |
| 2024-07-24 | $2.41 | $2.34 | +3.0% | $1.0B | $1.0B | -0.9% |
| 2024-04-24 | $2.14 | $1.97 | +8.6% | $997.4M | $974.5M | +2.3% |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4.03B | 4.00B | 3.86B | 3.73B | 3.95B | 2.47B | 2.41B | 1.97B | 1.47B | 1.08B | 845.49M | 761.65M |
| Net Income | 410.35M | 421.36M | 445.05M | 361.57M | 772.02M | 1.78B | 442.78M | 400.24M | 231.42M | 189.68M | 144.02M | 145.83M |
| EPS | 5.66 | 5.63 | 5.82 | 4.62 | 9.78 | 22.55 | 5.57 | 5.00 | 2.89 | 2.38 | 1.80 | 1.81 |
| Total Assets | 6.23B | 6.21B | 6.08B | 5.95B | 5.94B | 4.83B | 2.50B | 2.05B | 1.78B | 1.40B | 1.16B | 988.00M |
| Total Debt | 82.51M | 119.28M | 126.62M | 126.91M | 125.38M | 86.18M | 59.20M | 0 | 0 | 0 | 0 | 0 |
| Cash & Equivalents | 1.09B | 1.04B | 937.44M | 942.05M | 1.10B | 960.84M | 550.42M | 636.90M | 449.51M | 389.27M | 167.71M | 199.87M |
| Operating Cash Flow | 593.22M | 738.23M | 785.78M | 568.73M | 1.17B | 662.17M | 747.27M | 554.68M | 438.54M | 247.65M | 238.00M | 226.90M |
| Free Cash Flow | 593.22M | 622.65M | 608.06M | 276.83M | 771.45M | 507.26M | 597.56M | 331.37M | 242.84M | 177.08M | 184.55M | 202.81M |
| FCF per Share | 8.18 | 8.32 | 7.96 | 3.54 | 9.78 | 6.44 | 7.52 | 4.14 | 3.03 | 2.22 | 2.31 | 2.51 |
| Book Value | 4.05B | 3.85B | 3.63B | 3.60B | 3.62B | 3.23B | 1.35B | 1.25B | 1.15B | 995.39M | 847.93M | 752.77M |
| Cash & ST Investments | 1.09B | 1.04B | 972.74M | 999.58M | 1.17B | 960.84M | 868.63M | 735.36M | 721.54M | 640.26M | 527.29M | 454.66M |
| ROC Equity | 0.10 | 0.11 | 0.12 | 0.10 | 0.21 | 0.55 | 0.33 | 0.32 | 0.20 | 0.19 | 0.17 | 0.19 |